Occudo Quantitative Strategies’s Hanesbrands HBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-92,783
Closed -$425K 747
2025
Q2
$425K Buy
+92,783
New +$448K 0.05% 383
2025
Q1
Sell
-40,931
Closed -$333K 756
2024
Q4
$333K Buy
+40,931
New +$322K 0.06% 417
2024
Q3
Sell
-14,661
Closed -$72.3K 834
2024
Q2
$72.3K Buy
+14,661
New +$71.9K 0.01% 691
2024
Q1
Sell
-110,448
Closed -$493K 857
2023
Q4
$493K Sell
110,448
-46,105
-29% -$188K 0.07% 404
2023
Q3
$620K Buy
156,553
+74,209
+90% +$359K 0.08% 427
2023
Q2
$374K Sell
82,344
-141,345
-63% -$646K 0.04% 661
2023
Q1
$1.18M Buy
223,689
+124,968
+127% +$786K 0.11% 284
2022
Q4
$628K Sell
98,721
-79,958
-45% -$549K 0.07% 430
2022
Q3
$1.24M Buy
178,679
+166,319
+1,346% +$1.63M 0.1% 319
2022
Q2
$127K Buy
+12,360
New +$154K 0.01% 984
2022
Q1
Sell
-44,292
Closed -$741K 1205
2021
Q4
$741K Sell
44,292
-34,529
-44% -$587K 0.07% 470
2021
Q3
$1.35M Buy
78,821
+33,564
+74% +$629K 0.16% 172
2021
Q2
$845K Buy
+45,257
New +$896K 0.13% 260

Other funds holding HBI

Occudo Quantitative Strategies's HBI Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Hanesbrands (HBI) in Q3 2025, closing a stake of 92,783 shares — an estimated $425K sold.

Occudo Quantitative Strategies first reported a position in HBI in Q2 2021 and held it in 13 quarters. The position peaked at $1.35M in Q3 2021. 395 funds tracked by Wall St. Rank hold HBI as of Q3 2025.

  • Occudo Quantitative Strategies reported no remaining Hanesbrands position as of Q3 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 92,783 Hanesbrands shares in Q3 2025, an estimated $425K.
  • Occudo Quantitative Strategies first reported a position in Hanesbrands in Q2 2021 and held it in 13 quarters.
  • Occudo Quantitative Strategies's Hanesbrands position peaked at $1.35M in Q3 2021.
  • 395 funds tracked by Wall St. Rank held Hanesbrands as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.